CHARMD

Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database


  • TOP

    New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc.

    Mutations:

    Mutant Gene Virus Antiviral EC50 ratio Phenotype
    T37A UL89 Human betaherpesvirus 5 Natural polymorphism
    L89P UL89 Human betaherpesvirus 5 Natural polymorphism
    D94N UL89 Human betaherpesvirus 5 Natural polymorphism
    K95E UL89 Human betaherpesvirus 5 Natural polymorphism
    H216R UL89 Human betaherpesvirus 5 Natural polymorphism
    G239C UL89 Human betaherpesvirus 5 Natural polymorphism
    Q244H UL89 Human betaherpesvirus 5 Natural polymorphism
    Q249H UL89 Human betaherpesvirus 5 Natural polymorphism
    K253Q UL89 Human betaherpesvirus 5 Natural polymorphism
    K253T UL89 Human betaherpesvirus 5 Natural polymorphism
    E254A UL89 Human betaherpesvirus 5 Natural polymorphism
    R258P UL89 Human betaherpesvirus 5 Natural polymorphism
    A283P UL89 Human betaherpesvirus 5 Natural polymorphism
    N294D UL89 Human betaherpesvirus 5 Natural polymorphism
    S345A UL89 Human betaherpesvirus 5 Natural polymorphism
    T448I UL89 Human betaherpesvirus 5 Natural polymorphism
    C511F UL89 Human betaherpesvirus 5 Natural polymorphism
    I531V UL89 Human betaherpesvirus 5 Natural polymorphism
    L548V UL89 Human betaherpesvirus 5 Natural polymorphism
    G635S UL89 Human betaherpesvirus 5 Natural polymorphism
    A663V UL89 Human betaherpesvirus 5 Natural polymorphism
    D665E UL89 Human betaherpesvirus 5 Natural polymorphism
    A668P UL89 Human betaherpesvirus 5 Natural polymorphism
    F671S UL89 Human betaherpesvirus 5 Natural polymorphism
    R672K UL89 Human betaherpesvirus 5 Natural polymorphism


    Tilloy et al., 2024
    Interdeposit Digital Number: IDDN.FR.001.420004.000.S.X.2024.000.31230